Evolus Inc (EOLS) Event Aug. 02, 2022, 00:00 UTC 32 1 comments (47% Neutral) EVOLUS, INC. (EOLS) Reports 75% Loss Increase for 2022-06-30 Comment Full text
Phathom Pharmaceuticals Inc (PHAT) Event Aug. 02, 2022, 00:00 UTC 33 1 comments (61% Neutral) PHATHOM PHARMACEUTICALS, INC. (PHAT) Reports Net Loss for 2022-06-30 Comment Full text
Esperion Therapeutics Inc (ESPR) Event Aug. 02, 2022, 00:00 UTC 33 1 comments (42% Neutral) Esperion Therapeutics, Inc. (ESPR) Reports Net Loss for 2022-06-30 Comment Full text
Amicus Therapeutics Inc (FOLD) Event Aug. 01, 2022, 21:10 UTC 22 1 comments (99% Neutral) AMICUS THERAPEUTICS, INC. (FOLD) Announces New Board Appointment Comment Full text
Acumen Pharmaceuticals Inc (ABOS) Event Aug. 01, 2022, 21:06 UTC 22 1 comments (99% Neutral) Acumen Pharmaceuticals, Inc. (ABOS) Provides Update on appear for Alzheimer’s disease (AD) Comment Full text
Aclaris Therapeutics Inc (ACRS) Event Aug. 01, 2022, 20:45 UTC 22 1 comments (99% Neutral) Aclaris Therapeutics, Inc. (ACRS) Announces New Board Appointment Comment Full text
Cellectis (CLLS) Event Aug. 01, 2022, 20:30 UTC 19 1 comments (99% Neutral) Cellectis (CLLS) Announces Clinical Development Update (Form 6-K) Comment Full text
Aerie Pharmaceuticals Inc (the company is taken over Alcon (ALC)) (AERI) Event Aug. 01, 2022, 20:21 UTC 20 1 comments (85% Positive) AERIE PHARMACEUTICALS INC (AERI) Announces Enrollment Update for trials Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) Event Aug. 01, 2022, 20:01 UTC 18 1 comments (35% Negative) Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) Files Form 6-K Comment Full text
AstraZeneca (AZN) Event Aug. 01, 2022, 17:16 UTC 19 1 comments (99% Neutral) AstraZeneca (AZN) Files Form 6-K Comment Full text